“Blood Tumor Mutational Burden as a Predictive Biomarker in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)” (2026) Pakistan Journal of Medical & Cardiological Review, 5(2), pp. 2361–2369. doi:10.66021/pakmcr1041.